Thursday, 19 September 2019

Japan News

  • Astellas joins hands with Tecnofarma International

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jun, 2013

    Singapore: The US subsidiary of Japanese drug major Astellas Pharma has entered into a distribution agreement with Tecnofarma International to distribute enzalutamide (trade name Xtandi in ...Read more

  • BSA-CMR Survey: New CRO players emerge in APAC

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Alchemia gets US patent for oncology platform technology

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Mar, 2013

    Singapore: Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical to its platform oncology technology. The patent is being regarded as a ...Read more

  • Japan to develop vaccine for H7N9 bird flu

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

    Singapore: A panel of experts at the Health, Labor and Welfare Ministry of Japan will start producing a vaccine for the H7N9 strain of avian influenza, according to a report published by Th...Read more

  • Kitasato Daiichi Sankyo to shut animal vaccine unit

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

    Singapore: Daiichi Sankyo's animal vaccine unit, Kitasato Daiichi Sankyo Vaccine is discontinuing its animal vaccine business at the end of FY2013 in order to focus resources on vaccines fo...Read more

  • OptiMedica expands footprint in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2012

    Singapore: Global ophthalmic company OptiMedica has expanded international market adoption of its Catalys Precision Laser System with new installations at the premier Shinagawa LASIK Cente...Read more

  • WaferGen, Qiagen sign Next-Gen sequencing deal

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2013

    Singapore: WaferGen Bio-systems announced a co-marketing agreement with Qiagen for the promotion of certain products in Japan in the areas of genomics platforms such as Next-Gen sequencing ...Read more

  • Novartis's Ultibro Breezhaler receives EC, Japanese nod

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2013

    Singapore: Novartis has announced that the European Commission has approved once-daily Ultibro Breezhaler (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatm...Read more

  • Shimadzu India aims at 15-20% growth

    Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    With a view of expanding their customer base, Shimadzu Analytical India has been taking concrete steps towards connecting with their customers through various initiatives. Recently, it orga...Read more

  • Ex-GSK boss promoted as Takeda's CEO

    Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Japan's Takeda Pharmaceutical has promoted Mr Christophe Weber, representative director, president and chief operating Officer (COO), as the chief executive officer (CEO) of the ...Read more

  • Millennium starts ph III trial for multiple myeloma drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Singapore: Millennium: The Takeda Oncology Company, has initiated an international phase III clinical trial evaluating MLN9708 in patients with relapsed or refractory multiple myeloma. The ...Read more

  • Astellas looks to sell dermatology assets: Sources

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    Singapore: Japan-based drugmaker Astellas Pharma is planning to sell its dermatology portfolio, which could be worth between $500 million and $1 billion, according to the sources. Astellas...Read more

  • SymBio Pharma completes patient enrollment

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    Singapore: Japan-headquartered SymBio Pharmaceuticals has completed patient enrollment for its phase II clinical trial of Treakisym (bendamustine hydrochloride, SyB L-0501) in frontline low...Read more

  • OMRON reports performance for Q1 2012

    Japan |  Company results | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2012

    Singapore: OMRON Corporation reported consolidated performance for the first quarter (Q1) of fiscal 2012, which included the three months from April 1-to-June 30, 2012. Omron group's net sa...Read more

  • International consortium sequences tomato genome

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: The Tomato Genome Consortium (TGC), which is a group of over 300 scientists from 13 countries sequenced the genomes of the domesticated tomato and its wild ancestor, Solanum pimp...Read more

  • Japan approves world's first transdermal ß1-blocker patch

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2013

    Singapore: Japan-based Nitto Denko announced that Toa Eiyo has received manufacturing and marketing authorization in Japan from the Japanese Ministry of Health, Labour and Welfare for "Biso...Read more

  • Eisai, Toyama get marketing approval for iguratimod

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Singapore: Eisai and Toyama Chemical have received approval from Japan's Ministry of Health, Labour and Welfare to market iguratimod for the treatment of rheumatoid arthritis. Iguratimod, ...Read more

  • Daiichi to launch Inavir anti-influenza product in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Nov, 2012

    Singapore: Daiichi Sankyo submitted an application for a partial label change in Japan to manufacture and market the influenza anti-viral product Inavir Dry Powder Inhaler (laninamivir octa...Read more



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls